Anoro Ellipta (umeclidinium/vilanterol)

pCPA File Number: 20841
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CADTH Project Number:
SR0371-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: